Your browser doesn't support javascript.
loading
Process control: simply a matter of efficiency or of survival and costs? A single-centre quality improvement project in living donor renal transplant.
Paoletti, Filippo; Giorgio, Vittori; Jaser, Adel; Zanoni, Natalia Romina; Ricciardi, Walter; Citterio, Franco; De Belvis, Antonio Giulio.
Afiliação
  • Paoletti F; Clinical Pathways and Outcome Evaluation Unit, Fondazione Policlinico Universitario A.Gemelli IRCSS, Rome, Italy. filippopaoletti.an@gmail.com.
  • Giorgio V; Società Italiana di Ginecologia e Ostetricia, Rome, Italy.
  • Jaser A; Lean Program Unit, IREN, Turin, Italy.
  • Zanoni NR; Department of Medical and Surgical Sciences, Urology, Nephrology and Renal Transplant Area, Fondazione Policlinico Universitario A.Gemelli IRCSS, Rome, Italy.
  • Ricciardi W; Section of Hygiene, Department of Health Science and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Citterio F; Department of Medical and Surgical Sciences, Urology, Nephrology and Renal Transplant Area, Fondazione Policlinico Universitario A.Gemelli IRCSS, Rome, Italy.
  • De Belvis AG; Clinical Pathways and Outcome Evaluation Unit, Fondazione Policlinico Universitario A.Gemelli IRCSS, Rome, Italy.
BMC Health Serv Res ; 23(1): 192, 2023 Feb 23.
Article em En | MEDLINE | ID: mdl-36823623
BACKGROUND: Rising incidence and prevalence of end-stage renal disease is a worldwide concern for sustainability of healthcare systems and societies. Living donor renal transplant [LDRT] provides highest health achievements and cost containment than any alternative form of renal replacement therapy. Nonetheless, about 25% of potential LDRTs are missed for causes directly related with inadequate timing in donor assessment. Our quality improvement (QI) project implement process control tools and strategy aiming at reducing total evaluation time for donor candidates and minimizing dialysis exposure for intended recipients, which are the two main determinants of clinical outcomes and costs. METHODS: The study includes patients who underwent donor nephrectomy between January 1, 2017 and December 31, 2021. Six Sigma DMAIC approach was adopted to assess Base Case performance (Jan2017-Jun2019) and to design and implement our QI project. Study of current state analysis focused on distribution of time intervals within the assessment process, analysis of roles and impacts of involved healthcare providers and identification of targets of improvement. Improved Scenario (Jul2019-Dec2021) was assessed in terms of total lead time reduction, total pre-transplantation dialysis exposure and costs reduction, and increase in pre-emptive transplantations. The study was reported following SQUIRE 2.0 Guidelines for QI projects. RESULTS: Study population includes 63 patients, 37 in Base Case and 26 in Improved Scenario. Total lead time reduced from a median of 293 to 166 days and this in turn reduced pre-transplantation dialysis exposure and costs by 45%. Rate of potential pre-emptive donors' loss changes from 44% to 27%. CONCLUSIONS: Lean methodology is an effective tool to improve quality and efficiency of healthcare processes, in the interest of patients, healthcare professionals and payers.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Health_economic_evaluation / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Health_economic_evaluation / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article